Written by the Nuvirox Research Team
Short answer: NAD+ precursors activate brown fat tissue in lab dishes, but the one human trial that tested this directly found no effect on brown fat activity or cold-induced calorie burning in living people. A rare, clean example of a lab finding that didn't survive the jump to humans.
Key Points
- Brown adipose tissue (BAT) burns calories to generate heat, and NAD+ precursors activate it in isolated human fat cells in a dish.
- The one human clinical trial that tested this directly found NR supplementation did not change brown fat activity or cold-induced thermogenesis in vivo.
- Separately, cold exposure itself has been shown to naturally raise the body's own NAD+ precursor metabolites during the cold-response process.
Why cold exposure and NAD+ research crossed paths
Brown adipose tissue (BAT) is a specialized fat type that burns calories directly to generate heat rather than storing energy, and it's activated by cold exposure through the sympathetic nervous system. Because BAT activity relies heavily on mitochondrial uncoupling — a process that consumes significant metabolic resources — researchers hypothesized that boosting NAD+ availability might enhance BAT's calorie-burning capacity, particularly since earlier mouse studies found that NR supplementation in high-fat-diet-fed mice decreased weight gain and enhanced cold tolerance.
What the human trial actually found
Researchers directly tested this hypothesis in a study that combined lab and human components. In isolated human brown adipose tissue cells derived from biopsies, nicotinamide riboside did enhance norepinephrine-stimulated mitochondrial uncoupling — the cellular signature of calorie-burning activity — supporting the in-vitro mechanism. But the same researchers then tested oral NR supplementation directly in human volunteers (ages 45–65) using a placebo-controlled crossover design with actual cold exposure and PET imaging to measure real brown fat activity [1].
Study snapshot: NR and human brown adipose tissue — in vitro vs. in vivo
| In vitro finding | NR enhanced mitochondrial uncoupling in isolated human BAT cells |
| In vivo design | Placebo-controlled crossover, 1,000 mg/day NR, 6 weeks, cold exposure + PET imaging |
| In vivo finding | No change in BAT activity or cold-induced thermogenesis vs. placebo |
| Researchers' conclusion | NR stimulates BAT in vitro but not in vivo in humans |
The researchers' own conclusion was direct: NR stimulates human BAT activity when tested in isolated cells, but that effect did not translate into a measurable change in brown fat activity or calorie burning in living human volunteers exposed to actual cold. They explicitly noted this demonstrates the need for further translational research to understand the differences in NAD+ metabolism between mouse models and humans.
The other side of the connection: cold exposure changes your own NAD+ metabolism
Separately, and in the opposite direction of causality, researchers have found that cold exposure itself alters circulating levels of NAD+-related metabolites in humans — cold-stimulated brown fat activation was associated with changes in serum nicotinamide and related compounds, and experiments in human brown-fat-like ("brite") adipocytes found that nicotinamide exposure increased intracellular NAD+ and upregulated genes involved in thermogenesis. This is a genuinely interesting finding about how your body naturally shifts NAD+ metabolism in response to cold — but it's a different claim from "taking NAD+ supplements makes cold exposure work better," which is the claim the in-vivo human trial specifically tested and didn't find support for.
What NAD+ won't do
Based on the one direct human trial available, taking an NAD+ precursor supplement is not shown to enhance brown fat activation, boost calorie burning during cold exposure, or improve outcomes from cold plunges or cold therapy. If you're doing cold exposure for its own documented effects — which have separate research around mood, alertness, and other outcomes — there's no trial evidence that adding an NAD+ supplement meaningfully changes that experience or its results.
Why this null result matters
This is one of the cleaner examples in NAD+ research of a mechanism that looked strong in preclinical and cell-culture work but didn't hold up in a well-designed human trial using real physiological measurement (PET imaging during actual cold exposure, not just a blood marker). It's worth taking seriously precisely because it's not what supplement marketing typically emphasizes.
Frequently asked questions
Does taking NAD+ before a cold plunge boost fat burning?
The one direct human trial testing this found no effect on brown fat activity or cold-induced calorie burning, despite NAD+ precursors working in isolated human fat cells in a dish. There's no trial evidence supporting this combination.
Why did it work in cell studies but not in real people?
This is a known challenge in translational research — a mechanism that's real at the cellular level doesn't always produce a measurable whole-body effect, possibly due to how the supplement is metabolized and distributed differently in a living system versus an isolated cell culture.
Does cold exposure affect NAD+ on its own, without supplements?
Yes — separate research found cold exposure itself changes circulating NAD+-related metabolites as part of the body's natural thermogenic response. That's a different, and better-supported, finding than supplementation enhancing the cold response.
Should I stop taking NAD+ supplements if I do cold exposure regularly?
There's no reason to stop for safety reasons — just don't expect it to specifically enhance your cold exposure results, since the direct trial evidence doesn't support that particular combination.
If biohacking-style longevity interventions interest you broadly, our piece on NAD+ and the longevity diet covers the more traditional dietary angle, and for the general metabolic research behind NAD+ precursors, see NAD+ and metabolism and mitochondria supplements for which ingredients have the strongest human evidence.
Is it safe to combine cold exposure with NAD+ supplements?
There's no known safety concern with combining the two, though as with any new cold-exposure practice, people with cardiovascular conditions should check with a doctor before starting, independent of any supplement use.
The preclinical rationale for testing this in humans was reasonably strong going in, which is part of what makes the null in-vivo result notable. In high-fat-diet-fed mice, NR supplementation decreased weight gain, normalized glucose metabolism, and specifically enhanced cold tolerance compared to untreated mice — a fairly direct preclinical signal pointing toward exactly the human outcome the researchers then tested for. That a mechanism with this much preclinical support still didn’t translate into a measurable human brown-fat or thermogenesis effect is a useful, humbling data point for how much preclinical promise typically survives the jump into human trials across NAD+ research generally.
From Nuvirox
Why we formulated NAD+ Restore
Each serving provides 500 mg of nicotinamide riboside chloride (NR), one of the two most-researched NAD+ precursors, within the dose range used in published human trials. We paired it with 150 mg trans-resveratrol and 50 mg quercetin — polyphenols studied alongside NAD+ pathways for cellular health support — plus 10 mg of galactomannans from fenugreek to support absorption.
We back it with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about NAD+ Restore →The bottom line
This is a genuinely useful, if less exciting, finding: NAD+ precursors activate brown fat in isolated human cells, but the one trial that tested this in actual people, using cold exposure and real imaging, found no effect on brown fat activity or calorie burning. It's a clean reminder that cell-culture results don't always survive contact with human physiology — and a more honest answer than most cold-exposure-and-NAD+ content offers.
References
- Nicotinamide Riboside Enhances In Vitro Beta-adrenergic Brown Adipose Tissue Activity in Humans. J Clin Endocrinol Metab. 2021;106(5):1437-1452. PMID: 33524145.
- Cold-stimulated brown adipose tissue activation is related to changes in serum metabolites relevant to NAD+ metabolism in humans. Cell Rep. 2023.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.